Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

View source ↗

Summary

The document notes the completion of a clinical trial evaluating cerebral hemorrhage risk in hereditary hemorrhagic telangiectasia, sponsored by Unity Health To…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia | Status: COMPLETED